You have accessJournal of UrologyPediatrics: Basic Research1 Apr 2011264 A NEW BULKING AGENT TO TREAT VESOURETERAL REFLUX: AN EXPERIMENTAL STUDY Salvador Lima, Artur Rangel, Lamartine Aguiar, Francisco Sampaio, Luiz Cardoso, and Henrique Gomes Salvador LimaSalvador Lima Recife, Brazil More articles by this author , Artur RangelArtur Rangel Recife, Brazil More articles by this author , Lamartine AguiarLamartine Aguiar Recife, Brazil More articles by this author , Francisco SampaioFrancisco Sampaio Rio de Janeiro, Brazil More articles by this author , Luiz CardosoLuiz Cardoso Rio de Janeiro, Brazil More articles by this author , and Henrique GomesHenrique Gomes Rio de Janeiro, Brazil More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2011.02.355AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES The use of bulking agents in Urology became very popular especially after the approval of new agents suchs as Deflux. We present the experimental results of a new agent a cellulosic exopolysaccharide (CE), synthesized from sugar molasses by Zooglea sp [Paterson-Beedle. Carbohydr Polymers. 2000;42:375–383] with specific characteristics that can represent a new option in the treatment of VUR. METHODS Ten adult rabbits had the new agent injected into the bladder (submucosa) using a small abdominal incision. Three points in each half of the bladder were injected with 0.2ml of Deflux and the same amount of CE.The animals were sacrificed after 3 and 90 days, Collagen and elastic fibers were evidenced using the Sirius red and Weigert's resorsin fuchsin staining methods, respectively. Smooth muscle cells were identified by immunolabeling with smooth muscle alpha-actin. The density of blood vessels was assessed in oulined areas of injected material or normal bladder wall using the ImageJ software and HE-stained sections, and was expresed as as mean±SD number of blood vessels per mm2. RESULTS In 3-day samples, injected CE and Deflux were located mostly under the lamina propria and were structurally homogeneous and free from inflammatory cells or blood vessels. However, in 3-month samples, with the exception of a few small areas, CE was organized as short bundles, although the material stained weakly for collagen and was negative for elastic fibers, in contrast to the adjacent tissue. CE areas were populated by fibroblast-like cells, which were negative for smooth muscle immunolabeling. Newly formed blood vessels were also present in these areas, with a density 45.0±8.4, whereas in normal bladders the value was 35.2±2.9. A few small inflammatory infiltrates were observed in the CE areas, especially around blood vessels. Deflux areas in 3-month samples were fragmented but still homogeneous and free from cells or blood vessels. CONCLUSIONS The results obtained thus far indicate that this biomaterial exhibits little immunogenicity and integrates better in the host tissue as compared with Deflux. Therefore, CE should be an efficient material when incorporation is desired, for example as a suppportive scaffold in reconstructive surgery. CE may still be an effective bulking agent if its metabolizatin in the longer term does not involve reduction in volume. © 2011 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 185Issue 4SApril 2011Page: e106 Advertisement Copyright & Permissions© 2011 by American Urological Association Education and Research, Inc.MetricsAuthor Information Salvador Lima Recife, Brazil More articles by this author Artur Rangel Recife, Brazil More articles by this author Lamartine Aguiar Recife, Brazil More articles by this author Francisco Sampaio Rio de Janeiro, Brazil More articles by this author Luiz Cardoso Rio de Janeiro, Brazil More articles by this author Henrique Gomes Rio de Janeiro, Brazil More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...